3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
5
Terminated
5
Recruiting
5
Active not recruiting
4
Completed
3
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
98
Head and Neck Neoplasms
90
Nasopharyngeal Carcinoma
53
Thyroid Neoplasms
29
Mouth Neoplasms
24
Thyroid Cancer, Papillary
15
Oropharyngeal Neoplasms
13
Neoplasm Metastasis
13
Carcinoma, Squamous Cell
13
Carcinoma, Non-Small-Cell Lung
13
Laryngeal Neoplasms
12
Neoplasms
11
Uterine Cervical Neoplasms
10
Colorectal Neoplasms
10
Breast Neoplasms
10
Thyroid Nodule
8
Nasopharyngeal Neoplasms
7
Melanoma
7
Hypopharyngeal Neoplasms
7
Thyroid Diseases
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Triple Negative Breast Neoplasms
5
Sarcoma
5
Recurrence
5
Esophageal Neoplasms
5
Endometrial Neoplasms
5
Carcinoma, Renal Cell
5
Thyroid Carcinoma, Anaplastic
4
Stomach Neoplasms
4
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasms by Site
×
Head & Neck
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled